A citation-based method for searching scientific literature

Paulus Kirchhof, Stefano Benussi, Dipak Kotecha, Anders Ahlsson, Dan Atar, Barbara Casadei, Manuel Castella, Hans-Christoph Diener, Hein Heidbuchel, Jeroen Hendriks, Gerhard Hindricks, Antonis S Manolis, Jonas Oldgren, Bogdan Alexandru Popescu, Ulrich Schotten, Bart Van Putte, Panagiotis Vardas. Eur Heart J 2016
Times Cited: 3805







List of co-cited articles
351 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Dabigatran versus warfarin in patients with atrial fibrillation.
Stuart J Connolly, Michael D Ezekowitz, Salim Yusuf, John Eikelboom, Jonas Oldgren, Amit Parekh, Janice Pogue, Paul A Reilly, Ellison Themeles, Jeanne Varrone,[...]. N Engl J Med 2009
25

Apixaban versus warfarin in patients with atrial fibrillation.
Christopher B Granger, John H Alexander, John J V McMurray, Renato D Lopes, Elaine M Hylek, Michael Hanna, Hussein R Al-Khalidi, Jack Ansell, Dan Atar, Alvaro Avezum,[...]. N Engl J Med 2011
24

Rivaroxaban versus warfarin in nonvalvular atrial fibrillation.
Manesh R Patel, Kenneth W Mahaffey, Jyotsna Garg, Guohua Pan, Daniel E Singer, Werner Hacke, Günter Breithardt, Jonathan L Halperin, Graeme J Hankey, Jonathan P Piccini,[...]. N Engl J Med 2011
24

Edoxaban versus warfarin in patients with atrial fibrillation.
Robert P Giugliano, Christian T Ruff, Eugene Braunwald, Sabina A Murphy, Stephen D Wiviott, Jonathan L Halperin, Albert L Waldo, Michael D Ezekowitz, Jeffrey I Weitz, Jindřich Špinar,[...]. N Engl J Med 2013
19



Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials.
Christian T Ruff, Robert P Giugliano, Eugene Braunwald, Elaine B Hoffman, Naveen Deenadayalu, Michael D Ezekowitz, A John Camm, Jeffrey I Weitz, Basil S Lewis, Alexander Parkhomenko,[...]. Lancet 2014
16

Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study.
Sumeet S Chugh, Rasmus Havmoeller, Kumar Narayanan, David Singh, Michiel Rienstra, Emelia J Benjamin, Richard F Gillum, Young-Hoon Kim, John H McAnulty, Zhi-Jie Zheng,[...]. Circulation 2014
13

The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation.
Jan Steffel, Peter Verhamme, Tatjana S Potpara, Pierre Albaladejo, Matthias Antz, Lien Desteghe, Karl Georg Haeusler, Jonas Oldgren, Holger Reinecke, Vanessa Roldan-Schilling,[...]. Eur Heart J 2018
820
13


A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey.
Ron Pisters, Deirdre A Lane, Robby Nieuwlaat, Cees B de Vos, Harry J G M Crijns, Gregory Y H Lip. Chest 2010
12

2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society.
Craig T January, L Samuel Wann, Joseph S Alpert, Hugh Calkins, Joaquin E Cigarroa, Joseph C Cleveland, Jamie B Conti, Patrick T Ellinor, Michael D Ezekowitz, Michael E Field,[...]. J Am Coll Cardiol 2014
11


Impact of Renal Function on Outcomes With Edoxaban in the ENGAGE AF-TIMI 48 Trial.
Erin A Bohula, Robert P Giugliano, Christian T Ruff, Julia F Kuder, Sabina A Murphy, Elliott M Antman, Eugene Braunwald. Circulation 2016
151
7

The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: executive summary.
Jan Steffel, Peter Verhamme, Tatjana S Potpara, Pierre Albaladejo, Matthias Antz, Lien Desteghe, Karl Georg Haeusler, Jonas Oldgren, Holger Reinecke, Vanessa Roldan-Schilling,[...]. Europace 2018
117
6

Outcomes Associated With Apixaban Use in Patients With End-Stage Kidney Disease and Atrial Fibrillation in the United States.
Konstantinos C Siontis, Xiaosong Zhang, Ashley Eckard, Nicole Bhave, Douglas E Schaubel, Kevin He, Anca Tilea, Austin G Stack, Rajesh Balkrishnan, Xiaoxi Yao,[...]. Circulation 2018
179
6

2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.
Craig T January, L Samuel Wann, Hugh Calkins, Lin Y Chen, Joaquin E Cigarroa, Joseph C Cleveland, Patrick T Ellinor, Michael D Ezekowitz, Michael E Field, Karen L Furie,[...]. J Am Coll Cardiol 2019
605
6

Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trial.
Stefan H Hohnloser, Ziad Hijazi, Laine Thomas, John H Alexander, John Amerena, Michael Hanna, Matyas Keltai, Fernando Lanas, Renato D Lopes, Jose Lopez-Sendon,[...]. Eur Heart J 2012
363
6

Non-Vitamin K Antagonist Oral Anticoagulant Dosing in Patients With Atrial Fibrillation and Renal Dysfunction.
Xiaoxi Yao, Nilay D Shah, Lindsey R Sangaralingham, Bernard J Gersh, Peter A Noseworthy. J Am Coll Cardiol 2017
233
6

Antithrombotic Therapy for Atrial Fibrillation: CHEST Guideline and Expert Panel Report.
Gregory Y H Lip, Amitava Banerjee, Giuseppe Boriani, Chern En Chiang, Ramiz Fargo, Ben Freedman, Deirdre A Lane, Christian T Ruff, Mintu Turakhia, David Werring,[...]. Chest 2018
398
6

All-cause mortality in 272,186 patients hospitalized with incident atrial fibrillation 1995-2008: a Swedish nationwide long-term case-control study.
Tommy Andersson, Anders Magnuson, Ing-Liss Bryngelsson, Ole Frøbert, Karin M Henriksson, Nils Edvardsson, Dritan Poçi. Eur Heart J 2013
219
6


Impact of atrial fibrillation on the risk of death: the Framingham Heart Study.
E J Benjamin, P A Wolf, R B D'Agostino, H Silbershatz, W B Kannel, D Levy. Circulation 1998
6

Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation.
Christopher P Cannon, Deepak L Bhatt, Jonas Oldgren, Gregory Y H Lip, Stephen G Ellis, Takeshi Kimura, Michael Maeng, Bela Merkely, Uwe Zeymer, Savion Gropper,[...]. N Engl J Med 2017
650
5

Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI.
C Michael Gibson, Roxana Mehran, Christoph Bode, Jonathan Halperin, Freek W Verheugt, Peter Wildgoose, Mary Birmingham, Juliana Ianus, Paul Burton, Martin van Eickels,[...]. N Engl J Med 2016
783
5

Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation.
Renato D Lopes, Gretchen Heizer, Ronald Aronson, Amit N Vora, Tyler Massaro, Roxana Mehran, Shaun G Goodman, Stephan Windecker, Harald Darius, Jia Li,[...]. N Engl J Med 2019
393
5

Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium.
Roxana Mehran, Sunil V Rao, Deepak L Bhatt, C Michael Gibson, Adriano Caixeta, John Eikelboom, Sanjay Kaul, Stephen D Wiviott, Venu Menon, Eugenia Nikolsky,[...]. Circulation 2011
5

Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source.
Hans-Christoph Diener, Ralph L Sacco, J Donald Easton, Christopher B Granger, Richard A Bernstein, Shinichiro Uchiyama, Jörg Kreuzer, Lisa Cronin, Daniel Cotton, Claudia Grauer,[...]. N Engl J Med 2019
213
5

Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence.
Yoko Miyasaka, Marion E Barnes, Bernard J Gersh, Stephen S Cha, Kent R Bailey, Walter P Abhayaratna, James B Seward, Teresa S M Tsang. Circulation 2006
5


Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).
A John Camm, Paulus Kirchhof, Gregory Y H Lip, Ulrich Schotten, Irene Savelieva, Sabine Ernst, Isabelle C Van Gelder, Nawwar Al-Attar, Gerhard Hindricks, Bernard Prendergast,[...]. Eur Heart J 2010
5

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.
Piotr Ponikowski, Adriaan A Voors, Stefan D Anker, Héctor Bueno, John G F Cleland, Andrew J S Coats, Volkmar Falk, José Ramón González-Juanatey, Veli-Pekka Harjola, Ewa A Jankowska,[...]. Eur Heart J 2016
5

2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society.
Craig T January, L Samuel Wann, Joseph S Alpert, Hugh Calkins, Joaquin E Cigarroa, Joseph C Cleveland, Jamie B Conti, Patrick T Ellinor, Michael D Ezekowitz, Michael E Field,[...]. Circulation 2014
958
5

A new equation to estimate glomerular filtration rate.
Andrew S Levey, Lesley A Stevens, Christopher H Schmid, Yaping Lucy Zhang, Alejandro F Castro, Harold I Feldman, John W Kusek, Paul Eggers, Frederick Van Lente, Tom Greene,[...]. Ann Intern Med 2009
4

Off-Label Dosing of Non-Vitamin K Antagonist Oral Anticoagulants and Adverse Outcomes: The ORBIT-AF II Registry.
Benjamin A Steinberg, Peter Shrader, Laine Thomas, Jack Ansell, Gregg C Fonarow, Bernard J Gersh, Peter R Kowey, Kenneth W Mahaffey, Gerald Naccarelli, James Reiffel,[...]. J Am Coll Cardiol 2016
245
4

2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation.
Hugh Calkins, Gerhard Hindricks, Riccardo Cappato, Young-Hoon Kim, Eduardo B Saad, Luis Aguinaga, Joseph G Akar, Vinay Badhwar, Josep Brugada, John Camm,[...]. Heart Rhythm 2017
786
4

2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation.
Hugh Calkins, Gerhard Hindricks, Riccardo Cappato, Young-Hoon Kim, Eduardo B Saad, Luis Aguinaga, Joseph G Akar, Vinay Badhwar, Josep Brugada, John Camm,[...]. Europace 2018
389
4

Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial.
Douglas L Packer, Daniel B Mark, Richard A Robb, Kristi H Monahan, Tristram D Bahnson, Jeanne E Poole, Peter A Noseworthy, Yves D Rosenberg, Neal Jeffries, L Brent Mitchell,[...]. JAMA 2019
387
4

Lifetime risk for development of atrial fibrillation: the Framingham Heart Study.
Donald M Lloyd-Jones, Thomas J Wang, Eric P Leip, Martin G Larson, Daniel Levy, Ramachandran S Vasan, Ralph B D'Agostino, Joseph M Massaro, Alexa Beiser, Philip A Wolf,[...]. Circulation 2004
4

Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trial.
Pascal Vranckx, Marco Valgimigli, Lars Eckardt, Jan Tijssen, Thorsten Lewalter, Giuseppe Gargiulo, Valerii Batushkin, Gianluca Campo, Zoreslava Lysak, Igor Vakaliuk,[...]. Lancet 2019
220
4


Use of oral anticoagulants in patients with atrial fibrillation and renal dysfunction.
Tatjana S Potpara, Charles J Ferro, Gregory Y H Lip. Nat Rev Nephrol 2018
37
10

Warfarin use associates with increased risk for stroke in hemodialysis patients with atrial fibrillation.
Kevin E Chan, J Michael Lazarus, Ravi Thadhani, Raymond M Hakim. J Am Soc Nephrol 2009
301
4

Anticoagulation in Concomitant Chronic Kidney Disease and Atrial Fibrillation: JACC Review Topic of the Week.
Shankar Kumar, Emma Lim, Adrian Covic, Peter Verhamme, Chris P Gale, A John Camm, David Goldsmith. J Am Coll Cardiol 2019
31
12

Catheter Ablation for Atrial Fibrillation with Heart Failure.
Nassir F Marrouche, Johannes Brachmann, Dietrich Andresen, Jürgen Siebels, Lucas Boersma, Luc Jordaens, Béla Merkely, Evgeny Pokushalov, Prashanthan Sanders, Jochen Proff,[...]. N Engl J Med 2018
777
4

Effectiveness and Safety of Oral Anticoagulants Among Nonvalvular Atrial Fibrillation Patients.
Gregory Y H Lip, Allison Keshishian, Xiaoyan Li, Melissa Hamilton, Cristina Masseria, Kiran Gupta, Xuemei Luo, Jack Mardekian, Keith Friend, Anagha Nadkarni,[...]. Stroke 2018
108
4

Effectiveness and Safety of Dabigatran, Rivaroxaban, and Apixaban Versus Warfarin in Nonvalvular Atrial Fibrillation.
Xiaoxi Yao, Neena S Abraham, Lindsey R Sangaralingham, M Fernanda Bellolio, Robert D McBane, Nilay D Shah, Peter A Noseworthy. J Am Heart Assoc 2016
250
4

Trends in the prescription of novel oral anticoagulants in UK primary care.
Simone Y Loo, Sophie Dell'Aniello, Laetitia Huiart, Christel Renoux. Br J Clin Pharmacol 2017
131
4


Association between edoxaban dose, concentration, anti-Factor Xa activity, and outcomes: an analysis of data from the randomised, double-blind ENGAGE AF-TIMI 48 trial.
Christian T Ruff, Robert P Giugliano, Eugene Braunwald, David A Morrow, Sabina A Murphy, Julia F Kuder, Naveen Deenadayalu, Petr Jarolim, Joshua Betcher, Minggao Shi,[...]. Lancet 2015
234
4


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.